-
Je něco špatně v tomto záznamu ?
Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy?
A. Kroužecký, J. Chvojka, R. Sýkora, J. Raděj, T. Karvunidis, I. Novák, J. Růžička, Z. Petránková, J. Beneš, L. Bolek, M. Matějovič
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do 2017-12-31
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do 2017-12-31
Health & Medicine (ProQuest)
od 1997-01-01 do 2017-12-31
- MeSH
- akutní poškození ledvin MeSH
- hemofiltrace metody MeSH
- mimotělní oběh metody MeSH
- modely nemocí na zvířatech MeSH
- prasata MeSH
- renální insuficience terapie MeSH
- terapeutická hypotermie MeSH
- trombocytóza prevence a kontrola MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
OBJECTIVE: To test the hypothesis that cooling of blood in the extracorporeal circuit of continuous veno-venous hemofiltration (CVVH) enables to realize the procedure without the need of anticoagulation. DESIGN: Experimental animal study. METHODS: We developed the device for selective cooling of extracorporeal circuit (20 degrees C) allowing blood rewarming (38 degrees C) just before returning into the body. Twelve anesthetized and ventilated pigs were randomized to receive either 6 h of CVVH with application of this device (COOL; n = 6) or without it (CONTR; n = 6). MEASUREMENTS: Before the procedure and in 15, 60, 180, 360 min after starting hemofiltration variables related to: (1) circuit patency [time to clotting (TC), number of alarm-triggered pump stopping (AS), venous and transmembranous circuit pressures (VP, TMP)], (2) coagulation status in the extracorporeal circuit [thrombin-antithrombin complexes (TAT(circ)), thromboelastography (TEG)] and (3) animal status (hemodynamics, hemolysis and biochemistry) were assessed. RESULTS: The patency of all circuits treated with selective cooling was well maintained within the observation period. By contrast, five of six sessions were prematurely clotted in the untreated group. As a result, the number of AS was significantly higher in the CONTR group. In-circuit thrombus generation in CONTR group was associated with a markedly increasing TAT(circ). TEG performed at 180 min of the procedure revealed a tendency to a prolonged initial clotting time and a significant decrease in clotting rate of in-circuit blood in the COOL group. No signs of repeated cooling/rewarming-induced hemolysis were observed in animals treated with "hypothermic circuit" CVVH. CONCLUSION: In this porcine model, regional extracorporeal blood cooling proved effective in preventing in-circuit clotting without the need to use any other anticoagulant.
Citace poskytuje Crossref.org
- 000
- 03542naa 2200433 a 4500
- 001
- bmc11019707
- 003
- CZ-PrNML
- 005
- 20221005142813.0
- 008
- 110714s2009 xxu e eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00134-008-1271-9 $2 doi
- 035 __
- $a (PubMed)18802685
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kroužecký, Aleš, $d 1971- $7 xx0053033
- 245 10
- $a Regional cooling of the extracorporeal blood circuit: a novel anticoagulation approach for renal replacement therapy? / $c A. Kroužecký, J. Chvojka, R. Sýkora, J. Raděj, T. Karvunidis, I. Novák, J. Růžička, Z. Petránková, J. Beneš, L. Bolek, M. Matějovič
- 314 __
- $a ICU, 1st Medical Department, Charles University Medical School and Teaching Hospital, alej Svobody 80, 304 60, Plzen, Czech Republic.
- 520 9_
- $a OBJECTIVE: To test the hypothesis that cooling of blood in the extracorporeal circuit of continuous veno-venous hemofiltration (CVVH) enables to realize the procedure without the need of anticoagulation. DESIGN: Experimental animal study. METHODS: We developed the device for selective cooling of extracorporeal circuit (20 degrees C) allowing blood rewarming (38 degrees C) just before returning into the body. Twelve anesthetized and ventilated pigs were randomized to receive either 6 h of CVVH with application of this device (COOL; n = 6) or without it (CONTR; n = 6). MEASUREMENTS: Before the procedure and in 15, 60, 180, 360 min after starting hemofiltration variables related to: (1) circuit patency [time to clotting (TC), number of alarm-triggered pump stopping (AS), venous and transmembranous circuit pressures (VP, TMP)], (2) coagulation status in the extracorporeal circuit [thrombin-antithrombin complexes (TAT(circ)), thromboelastography (TEG)] and (3) animal status (hemodynamics, hemolysis and biochemistry) were assessed. RESULTS: The patency of all circuits treated with selective cooling was well maintained within the observation period. By contrast, five of six sessions were prematurely clotted in the untreated group. As a result, the number of AS was significantly higher in the CONTR group. In-circuit thrombus generation in CONTR group was associated with a markedly increasing TAT(circ). TEG performed at 180 min of the procedure revealed a tendency to a prolonged initial clotting time and a significant decrease in clotting rate of in-circuit blood in the COOL group. No signs of repeated cooling/rewarming-induced hemolysis were observed in animals treated with "hypothermic circuit" CVVH. CONCLUSION: In this porcine model, regional extracorporeal blood cooling proved effective in preventing in-circuit clotting without the need to use any other anticoagulant.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a akutní poškození ledvin $7 D058186
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a mimotělní oběh $x metody $7 D005112
- 650 _2
- $a hemofiltrace $x metody $7 D006440
- 650 _2
- $a terapeutická hypotermie $7 D007036
- 650 _2
- $a renální insuficience $x terapie $7 D051437
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a trombocytóza $x prevence a kontrola $7 D013922
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Chvojka, Jiří. $7 xx0240859
- 700 1_
- $a Sýkora, Roman, $d 1979- $7 xx0145769
- 700 1_
- $a Raděj, Jaroslav $7 xx0139911
- 700 1_
- $a Karvunidis, Thomas
- 700 1_
- $a Novák, Ivan, $d 1953- $7 mzk2002148285
- 700 1_
- $a Růžička, Jiří, $d 1969- $7 xx0074087
- 700 1_
- $a Petránková, Zuzana $7 xx0102442
- 700 1_
- $a Beneš, Jiří, $d 1954 leden 2.- $7 xx0060989
- 700 1_
- $a Bolek, Lukáš, $d 1961- $7 xx0074082
- 700 1_
- $a Matějovič, Martin, $d 1969- $7 nlk20030138334
- 773 0_
- $t Intensive Care Medicine $w MED00002258 $g Roč. 35, č. 2 (2009), s. 364-370
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110715115720 $b ABA008
- 991 __
- $a 20221005142808 $b ABA008
- 999 __
- $a ok $b bmc $g 864535 $s 729586
- BAS __
- $a 3
- BMC __
- $a 2009 $x MED00002258 $b 35 $c 2 $d 364-370 $m Intensive care medicine $n Intensive Care Med
- LZP __
- $a 2011-3B09/Bjvme